Clinical trial · Observational
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
NCT03094273CI-TRIAL-00038517completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Non-interventional study to evaluate the utility of removing Dysplastic Nevi with a defined 2 mm margin.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dysplastic Nevi | Cutaneous Dysplastic Nevus | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Saucerization biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Clear margins on the histopathological sections examined after a 2 mm saucerazation biopsy.
- timeFrame
- Up to 1 year
- description
- 2 mm saucerization biopsy
Secondary outcomes (1)
- measure
- Nevus recurrence rate
- timeFrame
- Up to 1 year
- description
- To determine the rate of nevus recurrence within 1 year of follow-up
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All patents seen in the practices of the study physicians are eligible to participate in the study. * Patients must be over 18 years of age. * Patients who are able to provide informed consent. * Patient must have a lesion in which the differential diagnosis includes a DN and for which the study dermatologist deems it is appropriate to perform a saucerization biopsy. Exclusion Criteria: * Patients who are less than 18 years of age. * Patients who are unable to provide informed consent. * Lesions for which a saucerization biopsy is impractical in the judgment of the study dermatologist based on certain clinical factors (e.g. patient on anticoagulation therapy, lesion size and/or anatomic location).
References
Publications (1)
- RESULTTerushkin V, Ng E, Stein JA, Katz S, Cohen DE, Meehan S, Polsky D. A prospective study evaluating the utility of a 2-mm biopsy margin for complete removal of histologically atypical (dysplastic) nevi. J Am Acad Dermatol. 2017 Dec;77(6):1096-1099. doi: 10.1016/j.jaad.2017.07.016. Epub 2017 Oct 2. PMID 28982585